Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset Pompe disease patient fibroblasts

NIAID Data Ecosystem2026-03-12 收录

庞贝病剪接调控

庞贝病药物干预

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155637 数据链接链接失效反馈

官方服务：

资源简介：

human Pompe Disease (c.-32-13T>G) fibroblasts were exposed to 10 µM Deferoxamine (DFX) or 0.1% DMSO (control condition), for three days. Three DMSO (CTR01Fib, CTR02Fib, CTR03Fib) and Deferoxamine (DFX04, DFX05, DFX06) independent treatments.

创建时间：

2021-01-19

Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset Pompe disease patient fibroblasts

资源简介：

相关数据集